Circulation
Circulation
Audio Summaries
Every issue of Circulation moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.
Specialties
Circulation covers research in these specialties.
Recent summaries
The latest articles summarized from Circulation.
Hedgehog Signaling-Dependent Heterochronic Control of Cardiomyocyte Differentiation Establishes Distinct Cardiac Progenitor Fields.
Nov 17, 2026
This study asks how the three cardiac progenitor fields (first heart field, second heart field, and juxta-cardiac field) are established at distinct times during embryogenesis, a question relevant to congenital heart disease. Using single-cell atlases, gastrulation-stage imaging, and two Hedgehog loss-of-function mouse models, the authors show that Hedgehog signaling acts non-cell-autonomously to delay cardiac differentiation in the second heart field and juxta-cardiac field, while the first heart field evades this signaling and differentiates rapidly. Partial loss of Hedgehog signaling caused premature cardiac differentiation, and complete loss prevented formation of the second heart field and juxta-cardiac field, suggesting a heterochronic mechanism that could serve as a general model for progenitor field emergence during organogenesis.
Transapical Beating-Heart Septal Myectomy for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Initial Clinical Experience.
Nov 16, 2026
This prospective study asked whether transapical beating-heart septal myectomy, guided by real-time transesophageal echocardiography, can safely relieve symptoms and improve cardiac function in patients with symptomatic, drug-refractory nonobstructive hypertrophic cardiomyopathy. In 97 consecutive patients, 87.6% met prespecified success criteria at 6 to 12 months, with marked gains in NYHA class, Kansas City Cardiomyopathy Questionnaire scores, stroke volume, and diastolic function, though the procedure caused one ventricular septal perforation resulting in a death. The authors conclude that the approach is a potentially promising option for this difficult-to-treat population but requires confirmation in controlled, multicenter trials.
Biatrial Versus Left Atrial Maze Ablation During Cardiac Valve Surgery for Persistent Atrial Fibrillation: The ABLATION Trial.
Nov 16, 2026
The authors asked whether a biatrial Cox-Maze IV lesion set is more effective than a left atrial-only maze lesion set for eliminating persistent atrial fibrillation during rheumatic mitral valve surgery. In this randomized trial of 323 patients, freedom from atrial tachyarrhythmias at 12 months was higher with biatrial ablation (78.7% vs 68.6%), while permanent pacemaker rates were noninferior between groups (97.0% vs 98.1% pacemaker-free). These results support biatrial ablation as the preferred lesion set when performing surgical ablation during valve surgery.
Immersive Reality in Cardiothoracic Surgical Education.
Nov 16, 2026
This review examines how immersive reality technologies (virtual, augmented, mixed, and extended reality) can be used in cardiothoracic surgical education, a field well suited to them given its complex 3D anatomy, minimally invasive and robotic approaches, and high-stakes team-based training. The authors ask whether these tools improve surgical learning and, if so, how they should be implemented in training programs. They conclude that current evidence, though limited by small, heterogeneous studies focused on surrogate measures, shows gains in knowledge, confidence, procedural accuracy, and simulator performance, and they propose an implementation framework while calling for validation of outcome-linked, competency-based curricula.
Surgical Treatment of Atrial Fibrillation.
Nov 16, 2026
This review examines whether surgical approaches can fill the gap left by catheter ablation, which has limited efficacy in patients with non-paroxysmal atrial fibrillation and enlarged left atria. The authors summarize recent evidence on patient selection, minimally invasive and hybrid epicardial-endocardial ablation, left atrial appendage exclusion, and postoperative anticoagulation. They report that the Cox-Maze IV procedure and hybrid ablation achieve higher five-year arrhythmia-free rates (roughly 85-95% and 60-70%, respectively) than thoracoscopic epicardial ablation or catheter ablation alone, suggesting a growing role for standalone surgical ablation in advanced disease.
Transapical Beating-Heart Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy.
Nov 16, 2026
This paper reviews transapical beating-heart septal myectomy (TA-BSM), a newer surgical approach for obstructive hypertrophic cardiomyopathy that avoids sternotomy, cardiopulmonary bypass, and aortotomy and uses real-time intraoperative echocardiography for guidance. The authors ask whether this simplified technique can offer a safer, more reproducible, and faster-recovering alternative to conventional septal myectomy, which is limited to high-volume centers. They conclude that TA-BSM reduces surgical trauma and recovery time, is feasible in challenging anatomies, and often resolves systolic anterior motion without mitral valve intervention, though multicenter studies are needed to define its role.
Degenerative Mitral Regurgitation: From Prolapse to Precision Therapy.
Nov 16, 2026
This review examines degenerative mitral regurgitation caused by mitral valve prolapse, which affects roughly 15 million people worldwide and is the most common reason for mitral intervention in high-income countries. The authors ask what remains poorly understood about its biology, natural history, and lifelong management, and they synthesize current knowledge on epidemiology, diagnosis, risk stratification, and treatment. They also highlight future directions, including genetic and cellular drivers of progression, detection of myocardial dysfunction in high-risk groups such as arrhythmic prolapse, and ongoing trials comparing surgical and transcatheter therapies.
Peripheral Artery Disease in Acute Care Settings: Diagnosis and Management of Common Presentations and Emergencies: A Scientific Statement From the American Heart Association.
Nov 16, 2026
This American Heart Association scientific statement addresses how peripheral artery disease (PAD) is recognized and managed in acute care settings, where it is often missed or undertreated and its risks are amplified by comorbid conditions. The authors aim to provide guidance on diagnosing common PAD presentations and emergencies, and on safely managing patients with PAD who require vascular access for procedures such as acute myocardial infarction treatment, cardiogenic shock care, or valve intervention, as well as those with recent vascular interventions or mechanical circulatory support.
Cardiovascular Health Promotion for US Veterans: Current State, Gaps, and Strategies: A Scientific Statement From the American Heart Association.
Nov 11, 2026
This American Heart Association scientific statement asks how well cardiovascular health is being promoted among US veterans and how the Department of Veterans Affairs (VA) system can help close remaining gaps. Applying the Life's Essential 8 framework (expanded to include mental health and substance use), the authors find that VA-enrolled veterans often achieve outcomes equal to or better than non-VA peers, but challenges remain in lifestyle behaviors, metabolic, lipid, and blood pressure control, mental health and substance use engagement, and sleep disorder care. They conclude that improving these areas will require expanding access, better digital data integration, tailored interventions for high-risk subgroups, and stronger implementation strategies.
Off-Pump versus On-Pump Coronary Artery Bypass Grafting in Prefrail and Frail Patients: 30-Day and 1-Year Outcomes From the FRAGILE Randomized Trial.
Nov 10, 2026
This randomized trial asked whether off-pump CABG (OPCAB) or on-pump CABG (ONCAB) leads to better outcomes in prefrail and frail patients aged 60 and older. In 508 patients, the 30-day composite of death, MI, stroke, renal failure, ARDS, or bleeding reoperation occurred in 10.9% of OPCAB and 16.0% of ONCAB patients, a difference that was not statistically significant (RR 1.47 [95% CI 0.94-2.31], P=0.09), though surgical wound infection was lower with OPCAB. The authors concluded that the two approaches produced similar rates of the primary composite outcome, with no significant differences in neurocognitive outcomes at 1 year.
